[VRDN] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
07-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -3.41%
YoY- -54.46%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 208 0 695 944 1,631 889 501 -13.61%
PBT -14,043 -5,494 -11,230 -9,011 -5,834 -1,839 -3,152 28.24%
Tax 91 -48 133 362 113 0 0 -
NP -14,043 -5,494 -11,230 -9,011 -5,834 -1,839 -3,152 28.24%
Tax Rate - - - - - - - -
Total Cost 14,251 5,494 11,925 9,955 7,465 2,728 3,653 25.44%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -6,751.44 0.00 -1,615.83 -954.56 -357.69 -206.86 -629.14 48.46%
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -1.26 -1.48 -5.42 -4.40 -4.06 -2.56 -5.82 -22.49%
EPS Diluted -1.26 -1.48 -5.42 -4.40 -4.06 -2.56 -5.82 -22.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.